Concepedia
Statistics
Publications
8
Citations
800
H-Index
Active since
2007
Affiliations
University of Groningen(Current)
University Medical Center Groningen
Leiden University Medical Center
ISA Pharmaceuticals (Netherlands)
Target (United States)
Baukje‐Nynke Hoogeboom is an author at University of Groningen specializing in immunology, oncology, and cancer immunology.
Publications per year
2007–2015
Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer
Ninke Leffers, Marloes J.M. Gooden, Renske A. de Jong et al. · Cancer Immunology Immunotherapy · 2008 · 397 citations · Full text
Medicine, Oncology, Pathology +17
Immunization with a P53 synthetic long peptide vaccine induces P53‐specific immune responses in ovarian cancer patients, a phase II trial
Ninke Leffers, Annechien J.A. Lambeck, Marloes J.M. Gooden et al. · International Journal of Cancer · 2009 · 141 citations
Medicine, Immunology, Oncology +17
Potentiation of a p53‐SLP vaccine by cyclophosphamide in ovarian cancer: A single‐arm phase II study
Renee Vermeij, Ninke Leffers, Baukje‐Nynke Hoogeboom et al. · International Journal of Cancer · 2011 · 97 citations · Full text
Long‐term clinical and immunological effects of p53‐SLP® vaccine in patients with ovarian cancer
Ninke Leffers, Renee Vermeij, Baukje‐Nynke Hoogeboom et al. · International Journal of Cancer · 2011 · 60 citations
P53‐specific T cell responses in patients with malignant and benign ovarian tumors: Implications for p53 based immunotherapy
Annechien J.A. Lambeck, Ninke Leffers, Baukje‐Nynke Hoogeboom et al. · International Journal of Cancer · 2007 · 35 citations · Full text
Life Sciences, Immunology, Oncology +17
1–5 of 8